Managing Gout in Primary CareEvolving Strategies for Diagnosis and Long-Term Management
Cavagna L, Taylor WJ. BioMed Res Int. 2014. doi: 10.1155/2014/264859. Epub 2014 Apr 16.
Chowalloor PV, et al. Ther Adv Musculoskelet Dis. 2014;6(4):131-143.
Diaz-Torné C, et al. Curr Opin Rheumatol. 2015;27(2):164-169.
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia.
Fleischmann R, et al. Rheumatology. 2014;53(12):2167-2174.
The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality.
Gustafsson D, Unwin R. BMC Nephrology. 2013;14:164.
Edwards NL, So A. Rheum Dis Clin North Am. 2014;40(2):375-387.
The association of gout with socioeconomic status in primary care: a cross-sectional observational study.
Hayward RA, et al. Rheumatology (Oxford). 2013;52(11):2004-2008.
Martillo MA, et al. Curr Rheumatol Rep. 2014;16(2):400. doi:10.1007/s11926-013-0400-9.
Singh JA. Curr Rheumatol Rep. 2013;15(2):307. doi:10.1007/s11926-012-0307-x.
Stamp LK, Chapman PT. Rheumatology (Oxford). 2013;52(1):34-44.
Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials.
Strand V, et al. J Rheumatol. 2012;39(7):1450-1457.
Suresh E, Das P. QJM. 2012;105(5):407-417.
Clinical Updates on the Management of Gout
Michael H. Pillinger, MD
Updates on Diagnosis and Evidence-Based Management
Improved Diagnostic and Management Strategies
Long-Term Management Strategies to Improve Patient Outcomes
Overcoming Pain and Gastrointestinal Distress to Improve Patient Outcomes
Evidence-Based Strategies for Improved Patient Outcomes
Proactive Diagnosis and Targeted Management
Differential Diagnosis and Comprehensive Management Strategies
Optimizing Maintenance Therapy Across Healthcare Settings
Consensus and Controversies for Responsible Opioid Prescribing
Best Practices in Combination Therapy
Evolving Approaches to Insulin Based Therapy
Treating to Target, IL-6-Directed Therapies, and Evolving Management Algorithms
Improving Outcomes for Patients with COPD
New Strategies for Insulin Replacement Therapy
Clinical Updates in LDL-C Management
Improving Comprehensive Patient Care
Identifying Patients and Tailoring Therapy
Collaborative Approaches to Guideline-Concordant Patient Care
New Strategies for Individualizing Long-term Care
A Focus on Patients With Opioid-Induced Constipation
Consensus and Controversies Across the Spectrum of Patient Presentations
Evolving Treatment Algorithms and Expert Perspectives on Biosimilars
Pathophysiology to the Management of Moderate-to-Severe Disease
Evolving Best Practices to Optimize Outcomes
Targeting Immune Dysregulation and Delivering Comprehensive Care
The PCP’s Role in Timely Recognition and Referral
Translating Comprehensive Patient Evaluations Into Personalized Therapy
Looking Beyond Barriers to Optimize Therapy
New Perspectives on Targeting Remission and Individualizing Therapy
Using Imaging to Improve Patient Outcomes
Discussions and Debates on the Evolving Roles of Targeted Synthetic DMARDs
Differential Diagnosis, Multidisciplinary Management, and Patient Engagement
Key Issues Impacting OB/GYN Practice
Translating Pathophysiology into Targeted Treatments
Think You Know JAK?
An Interactive Experience Highlighting Recent Clinical Advances
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Debates & Discussions on the Evolving Role of JAK Inhibitors